The company
Outset Medical, Inc.
OM · Nasdaq
OM stood above a rising 150-day average in 3 of the last 52 weekly readings, and has been out of that trend for the last 9 weeks. It is 5.1% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Setting up
- Weeks in an uptrend
- out for 9
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $870K
- Insider sales, 12 months
- $724K
- Officials’ trades on record
- 0
- Institutions holding
- 86 (-4)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 3 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Braden Michael Leonard10% owner | bought | 16,575at $3.88 | 2 Oct 2026filed 5 Oct 2026 |
| Braden Michael Leonard10% owner | bought | 228,334at $3.53 | 1 Oct 2026filed 5 Oct 2026 |
| Renee GaetaChief Financial Officer | sold | 4,543at $4.39 | 17 Aug 2026filed 18 Aug 2026 |
| John L. BrottemGeneral Counsel | sold | 2,632at $4.39 | 17 Aug 2026filed 18 Aug 2026 |
| Leslie TriggChair and CEO | sold | 3,437at $4.39 | 17 Aug 2026filed 18 Aug 2026 |
| Renee GaetaChief Financial Officer | sold | 17,672at $4.94 | 3 Jun 2026filed 5 Jun 2026 |
| John L. BrottemGeneral Counsel | sold | 2,638at $3.70 | 15 May 2026filed 19 May 2026 |
| Marc NashEVP Operations R&D & Service | sold | 1,582at $3.70 | 15 May 2026filed 19 May 2026 |
| Leslie TriggChair and CEO | sold | 3,445at $3.70 | 15 May 2026filed 19 May 2026 |
| Leslie TriggChair and CEO | sold | 3,361at $3.35 | 17 Feb 2026filed 19 Feb 2026 |
| John L. BrottemGeneral Counsel | sold | 2,842at $3.35 | 17 Feb 2026filed 19 Feb 2026 |
| Marc NashEVP Operations R&D & Service | sold | 1,817at $3.35 | 17 Feb 2026filed 19 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| FMR LLCadded · filed 13 Aug 2026 | 2,742,887$11.8M | +1,2140.0% |
| BML Capital Management, LLCadded · filed 7 Aug 2026 | 2,519,701$10.9M | +617,500+32.5% |
| AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026 | 998,961$4.3M | +190,676+23.6% |
| PERCEPTIVE ADVISORS LLCunchanged · filed 14 Aug 2026 | 833,333$3.6M | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 780,134$3.4M | +16,312+2.1% |
| BANK OF AMERICA CORPreduced · filed 14 Aug 2026 | 665,847$2.9M | -283,550−29.9% |
| PFM Health Sciences, LPreduced · filed 14 Aug 2026 | 582,122$2.5M | -12,508−2.1% |
| Ensign Peak Advisors, Increduced · filed 14 Aug 2026 | 434,341$1.9M | -92,244−17.5% |
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 418,211$1.8M | -845,008−66.9% |
| Assenagon Asset Management S.A.reduced · filed 8 Jul 2026 | 339,438$1.5M | -164,655−32.7% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.